Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.

We have followed one patient with Philadelphia (Ph)-negative chronic myelogenous leukemia and identified an additional four patients from the literature who showed the rearrangement in the breakpoint cluster region (bcr) on chromosome 22 characteristic of Ph-positive chronic myelogenous leukemia. The clinical course of these five patients was similar to that of Ph-positive patients, with easily controlled leukocyte counts, a prolonged benign phase, and prolonged survival. Furthermore, we have shown, for the first time, that bcr rearrangement in Ph-negative chronic myelogenous leukemia can result in expression of the aberrant 210-kilodalton bcr-abl fusion protein, which has been strongly implicated in Ph-positive leukemogenesis. Research data pertaining to possible cytogenetic mechanisms leading to production of p210bcr-abl in the absence of the Ph chromosome are reviewed. Molecular analysis provides an important tool for classifying and predicting prognosis of some patients with Ph-negative chronic myelogenous leukemia.

[1]  A. Reeve,et al.  Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia , 1986, Nature.

[2]  P. Nowell,et al.  Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Dewald,et al.  Ph1-negative chronic granulocytic leukemia: a nonentity. , 1986, American journal of clinical pathology.

[4]  N. Heisterkamp,et al.  Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. , 1985, The New England journal of medicine.

[5]  C. Bartram.  Brief Definitive Report , 2022 .

[6]  O. Witte,et al.  Activation of the abl oncogene in murine and human leukemias. , 1985, Biochimica et biophysica acta.

[7]  O. Witte,et al.  Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products , 1985, Molecular and cellular biology.

[8]  A. Hagemeijer,et al.  Translocation of c-abl to "masked" Ph in chronic myeloid leukemia. , 1985, Cancer genetics and cytogenetics.

[9]  S. Sacchi,et al.  Chromosomal abnormalities in essential thrombocythemia. , 1985, Cancer genetics and cytogenetics.

[10]  J. Rowley,et al.  Philadelphia chromosome‐negative chronic myelogenous leukaemia: a morphological reassessment , 1985, British journal of haematology.

[11]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[12]  N. Heisterkamp,et al.  C‐abl and bcr are rearranged in a Ph1‐negative CML patient. , 1985, The EMBO journal.

[13]  R. Kurzrock,et al.  The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. , 1985, Virology.

[14]  A. Hagemeijer,et al.  Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? , 1984, Cancer genetics and cytogenetics.

[15]  M. Groudine,et al.  Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. , 1984, Science.

[16]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[17]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[18]  J. Lazerson,et al.  Chronic myelogenous leukemia and genetic events at 9q34 , 2007, Hematological oncology.

[19]  J. Stephenson,et al.  Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia , 1983, Nature.

[20]  J. Stephenson,et al.  Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.

[21]  C. Sahasrabuddhe,et al.  Long-term growth of human B cells and their use in a microassay for B-cell growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Koeffler Hp,et al.  Chronic myelogenous leukemia--new concepts (first of two parts). , 1981 .

[23]  A. Sandberg.  Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML , 1980, Cancer.

[24]  S. Cohen,et al.  Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. , 1980, The Journal of biological chemistry.

[25]  V. Najfeld,et al.  Involvement of the B-lymphoid system in chronic myelogenous leukaemia , 1980, Nature.

[26]  M. Kirschner,et al.  Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes , 1980, Cell.

[27]  T. Hunter,et al.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.

[28]  J. Rowley.  Chromosome abnormalities in human leukemia. , 1980, Annual review of genetics.

[29]  A. Sandberg,et al.  The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1‐negative chronic myelocytic leukemia (CML) , 1979, American journal of hematology.

[30]  A. Cork,et al.  Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. , 1979, Blood.

[31]  J. Rowley,et al.  Evolution of karyotypes in philadelphia (Ph1) chromosome‐negative chronic myelogenous leukemia , 1979, Cancer.

[32]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[33]  D. Bergsma.  An international system for human cytogenetic nomenclature (1978), ISCN (1978). Report of the Standing Committee on Human Cytogenetic Nomenclature. , 1978, Birth defects original article series.

[34]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.

[35]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[36]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[37]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[38]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[39]  A. Sandberg,et al.  Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. , 1970, Annals of internal medicine.

[40]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .